Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Molecular cloning of beta 3 subunit, a third form of the G protein beta-subunit polypeptideM A Levine, P M Smallwood, P T Moen, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.
Annales Pharmaceutiques Francaises|May 1, 1974
[Influence of various salts, polyhydroxylated agents and absorbents upon the determination of organic bases by anionic tensioactive agents in biphasic systems]A L Helman, M M Flores, H Gerschocvich, et al.
DNA and Cell Biology|March 21, 1998
p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cellsL Zhang, Q Zhan, S Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growthPatrick J Grohar, Laure E Segars, Choh Yeung, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumorLarisa V Debelenko, Diane C Arthur, Svetlana D Pack, et al.
Cancer Research|May 2, 2020
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood RhabdomyosarcomaKatherine K Slemmons, Choh Yeung, Joshua T Baumgart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
The Journal of Clinical Investigation|February 1, 1991
Insulin-like growth factor II-mediated proliferation of human neuroblastomaO M El-Badry, L J Helman, J Chatten, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Molecular cloning of beta 3 subunit, a third form of the G protein beta-subunit polypeptideM A Levine, P M Smallwood, P T Moen, et al.
Cancer Research|February 3, 2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumorsLeon T van den Broeke, C David Pendleton, Crystal Mackall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.
Annales Pharmaceutiques Francaises|May 1, 1974
[Influence of various salts, polyhydroxylated agents and absorbents upon the determination of organic bases by anionic tensioactive agents in biphasic systems]A L Helman, M M Flores, H Gerschocvich, et al.
DNA and Cell Biology|March 21, 1998
p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cellsL Zhang, Q Zhan, S Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growthPatrick J Grohar, Laure E Segars, Choh Yeung, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumorLarisa V Debelenko, Diane C Arthur, Svetlana D Pack, et al.
Cancer Research|May 2, 2020
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood RhabdomyosarcomaKatherine K Slemmons, Choh Yeung, Joshua T Baumgart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
The Journal of Clinical Investigation|February 1, 1991
Insulin-like growth factor II-mediated proliferation of human neuroblastomaO M El-Badry, L J Helman, J Chatten, et al.
Pageof 22